Amy R Copeland

Title: Amy R. Copeland: Inventor in T-Cell Immunotherapy

Introduction

Amy R. Copeland is an inventor based in Washington, DC, whose work includes a patented method for identifying T cells with potential relevance to immunotherapy. Her patent is assigned to the United States of America, as Represented by the Secretary, Department of Health and Human Services.

Latest Patents

Copeland is named on 1 patent: “Methods of Isolating T Cells and T-Cell Receptors from Peripheral Blood by Single-Cell Analysis for Immunotherapy.” The invention describes methods for isolating T cells from a patient’s blood, selecting cells based on gene-expression profiles, and separating selected cells to create an enriched population with specificity for a target antigen. It also covers T-cell receptor isolation, cells that express those receptors, pharmaceutical compositions, and methods for treating or preventing conditions in mammals.

Career Highlights

The patent reflects work at the intersection of single-cell analysis and immunotherapy. By focusing on the identification and enrichment of antigen-specific T cells, the disclosed methods aim to support the development of cell-based treatments.

Collaborations

Copeland’s listed coworkers include Sri Krishna and Rami Yoseph. The patent is assigned to the U.S. Department of Health and Human Services, represented by its Secretary.

Conclusion

Amy R. Copeland’s patent contribution centers on methods for identifying and enriching antigen-specific T cells, connecting single-cell analysis with potential immunotherapy applications.